Androgen and estrogen receptors have been shown to intersect with the HIF/NF-kB signaling in prostate cancer (Russo et al., 2016), and hypoxia increases androgen receptor activity (Park et al., 2006) within a low-androgen environment (Mitani et al., 2011). Here, ESR1 is linked to prostate cancer.